I think the point of the proactive video was to say... It will be difficult to show improvement in critical indication of Covid here in the USA. The realization of Nader to see this is good for our investment. Greener pastures are out there in other countries. We will be very valued in other countries and we will prove that. The piece meal that the FDA put together has reduced death effectively.

This doesn’t mean we threw in the towel on our other indications and are moving our headquarters overseas. We will still complete our other trials for Long Haulers and Cancer and any other indications we want to attempt with revenue we achieve internationally.

Long haulers could be the biggest indication for us and not just here in the USA but all over the world. We can’t underestimate the size of this population or length of time needed for this indication.

Nader has always kept the FDA in his sights for approvals and moving critical trials to another country isn’t a move he took lightly I am sure. The future is as bright as ever in my eyes. Going international just lit the high speed fuse to quick revenue. As for licensing and distribution. We need no partners after revenue starts. The future BiG Pharma we will know as CYDY is on it way to massive growth. Let’s sit back and enjoy the ride.